BeStock  

Neurocrine Biosciences NBIX

US equityMarket cap rank #1096Drug Manufacturers - Specialty & Generic
$150.57 −$6.02 (-3.84%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $150.57 0.00%
Open$156.27
Prev close$156.59
Day range$150.24 – $158.26
Volume1.59M
Market cap$15.24B
P/E (TTM)22.3
Dividend yield–

NBIX Stock News

Headlines matching Neurocrine Biosciences or the NBIX ticker, most recent first.

  • Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $253Market news · 4 Sep 2026 · Direct mention
  • Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $253 PositiveMarket news · 3 Sep 2026 · Direct mention
  • UBS Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $214 NegativeMarket news · 29 Sep 2026 · Direct mention
  • Bernstein Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $218Market news · 26 Sep 2026 · Direct mention
  • Neurocrine (NBIX) Receives a Buy From CCB Intl.TipRanks · 21 Sep 2026 · Direct mention
  • RBC Capital Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $198Market news · 15 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Raises Target Price to $183 PositiveMarket news · 11 Sep 2026 · Direct mention
  • J.P. Morgan Reaffirms Their Buy Rating on Neurocrine (NBIX)TipRanks · 7 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Announces Target Price $217Market news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Neurocrine Biosciences(NBIX.US), With a Forecast Between $194 to $249Market news · 4 Aug 2026 · Direct mention
  • CCORF Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $210 PositiveMarket news · 3 Aug 2026 · Direct mention
  • Citi Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $249Market news · 3 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $182Market news · 25 Aug 2026 · Direct mention
  • BMO Capital Maintains Neurocrine Biosciences(NBIX.US) With Hold Rating, Maintains Target Price $190Market news · 18 Aug 2026 · Direct mention
  • Evercore Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $215 PositiveMarket news · 17 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on NBIX.

Sign in to join the discussion.

Scroll to Top